161 related articles for article (PubMed ID: 25596131)
1. Pam2 lipopeptides systemically increase myeloid-derived suppressor cells through TLR2 signaling.
Maruyama A; Shime H; Takeda Y; Azuma M; Matsumoto M; Seya T
Biochem Biophys Res Commun; 2015 Feb; 457(3):445-50. PubMed ID: 25596131
[TBL] [Abstract][Full Text] [Related]
2. Serum inhibits the immunosuppressive function of myeloid-derived suppressor cells isolated from 4T1 tumor-bearing mice.
Hamilton MJ; Banáth JP; Lam V; Lepard NE; Krystal G; Bennewith KL
Cancer Immunol Immunother; 2012 May; 61(5):643-54. PubMed ID: 22021068
[TBL] [Abstract][Full Text] [Related]
3. TLR2 and caspase-1 signaling are critical for bacterial containment but not clearance during craniotomy-associated biofilm infection.
Aldrich AL; Heim CE; Shi W; Fallet RW; Duan B; Kielian T
J Neuroinflammation; 2020 Apr; 17(1):114. PubMed ID: 32290861
[TBL] [Abstract][Full Text] [Related]
4. Aminoacyl-tRNA synthetase-interacting multifunctional protein 1 suppresses tumor growth in breast cancer-bearing mice by negatively regulating myeloid-derived suppressor cell functions.
Hong HJ; Lim HX; Song JH; Lee A; Kim E; Cho D; Cohen EP; Kim TS
Cancer Immunol Immunother; 2016 Jan; 65(1):61-72. PubMed ID: 26613952
[TBL] [Abstract][Full Text] [Related]
5. Fibrinogen-like protein 2 promotes tumor immune suppression by regulating cholesterol metabolism in myeloid-derived suppressor cells.
Wu L; Liu X; Lei J; Zhang N; Zhao H; Zhang J; Deng H; Li Y
J Immunother Cancer; 2023 Dec; 11(12):. PubMed ID: 38056898
[TBL] [Abstract][Full Text] [Related]
6. MiR-9 promotes G-MDSC recruitment and tumor proliferation by targeting SOCS3 in breast cancer.
Gu X; Wei F; Tong J; Liu Y; Chen S; Zheng L; Xing Y
FASEB J; 2024 Jan; 38(1):e23388. PubMed ID: 38145323
[TBL] [Abstract][Full Text] [Related]
7. Human integrin α(3)β(1) regulates TLR2 recognition of lipopeptides from endosomal compartments.
Marre ML; Petnicki-Ocwieja T; DeFrancesco AS; Darcy CT; Hu LT
PLoS One; 2010 Sep; 5(9):e12871. PubMed ID: 20877569
[TBL] [Abstract][Full Text] [Related]
8. Anti-Gr-1 antibody depletion fails to eliminate hepatic myeloid-derived suppressor cells in tumor-bearing mice.
Ma C; Kapanadze T; Gamrekelashvili J; Manns MP; Korangy F; Greten TF
J Leukoc Biol; 2012 Dec; 92(6):1199-206. PubMed ID: 23077247
[TBL] [Abstract][Full Text] [Related]
9. MDSCs-derived GPR84 induces CD8
Liu J; Liu J; Qin G; Li J; Fu Z; Li J; Li M; Guo C; Zhao M; Zhang Z; Li F; Zhao X; Wang L; Zhang Y
J Immunother Cancer; 2023 Nov; 11(11):. PubMed ID: 38016719
[TBL] [Abstract][Full Text] [Related]
10. Listeria-vectored cervical cancer vaccine candidate strains reduce MDSCs via the JAK-STAT signaling pathway.
Zhang Y; Lei Y; Ou Q; Chen M; Tian S; Tang J; Li R; Liang Q; Chen Z; Wang C
BMC Biol; 2024 Apr; 22(1):88. PubMed ID: 38641823
[TBL] [Abstract][Full Text] [Related]
11. MDSC suppresses T cell antitumor immunity in CAC via GPNMB in a MyD88-dependent manner.
Wang B; Wang L; Shang R; Xie L
Cancer Med; 2023 Dec; 13(1):. PubMed ID: 38140790
[TBL] [Abstract][Full Text] [Related]
12. Myeloid-derived suppressor cells in non-neoplastic inflamed organs.
Sendo S; Saegusa J; Morinobu A
Inflamm Regen; 2018; 38():19. PubMed ID: 30237829
[TBL] [Abstract][Full Text] [Related]
13. A dietary commensal microbe enhances antitumor immunity by activating tumor macrophages to sequester iron.
Sharma G; Sharma A; Kim I; Cha DG; Kim S; Park ES; Noh JG; Lee J; Ku JH; Choi YH; Kong J; Lee H; Ko H; Lee J; Notaro A; Hong SH; Rhee JH; Kim SG; De Castro C; Molinaro A; Shin K; Kim S; Kim JK; Rudra D; Im SH
Nat Immunol; 2024 May; 25(5):790-801. PubMed ID: 38664585
[TBL] [Abstract][Full Text] [Related]
14. Intravenous administration of IL-12 encoding self-replicating RNA-lipid nanoparticle complex leads to safe and effective antitumor responses.
Wang Z; Chen Y; Wu H; Wang M; Mao L; Guo X; Zhu J; Ye Z; Luo X; Yang X; Liu X; Yang J; Sheng Z; Lee J; Guo Z; Liu Y
Sci Rep; 2024 Mar; 14(1):7366. PubMed ID: 38548896
[TBL] [Abstract][Full Text] [Related]
15. TLR9 promotes monocytic myeloid-derived suppressor cell induction during JEV infection.
Lian T; Zhang W; Su H; Yu Q; Zhang H; Zou Q; Chen H; Xiong W; Zhang N; Wang K; Zhao L; Fu ZF; Cui M
Microbes Infect; 2024 May; ():105336. PubMed ID: 38724001
[TBL] [Abstract][Full Text] [Related]
16. Deleterious intestinal inflammation in neonatal mice treated with TLR2/TLR6 agonists.
Fernandez M; Pezier T; Papadopoulos S; Laurent F; Werts C; Lacroix-Lamandé S
J Leukoc Biol; 2024 Jun; ():. PubMed ID: 38872374
[TBL] [Abstract][Full Text] [Related]
17. Triggering of Toll-like Receptor-2 in Mouse Myelomonocytic Leukaemia Cells WEHI-3B Leads to the Suppression of Apoptosis and Promotes Tumor Progression in Vivo.
Shcheblyakov DV; Logunov DY; Rakovskaya IV; Shmarov MM; Naroditsky BS; Ginzburg AL
Acta Naturae; 2011 Oct; 3(4):83-93. PubMed ID: 22649707
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, evaluation and molecular dynamics study of human toll-like receptor 2/6 specific monoacyl lipopeptides as candidate immunostimulants.
Zhu Y; Liu B; Chen Z; Wang X; Wang Y; Zhang W; Wang S; Zhang M; Li Y
Bioorg Chem; 2023 Dec; 141():106823. PubMed ID: 37708825
[TBL] [Abstract][Full Text] [Related]
19. LC3-dependent extracellular vesicles promote M-MDSC accumulation and immunosuppression in colorectal cancer.
Gu Y; Liu Q; He Q; Wu Q; Li L; Xu D; Zheng L; Xie L; Cheng S; Shen H; Zhou Y; Yang J; Jin H; Zhang X
iScience; 2024 May; 27(5):109272. PubMed ID: 38706868
[TBL] [Abstract][Full Text] [Related]
20. Loss of Anti-Tumor Efficacy by Polyamine Blocking Therapy in GCN2 Null Mice.
Alexander ET; Fahey E; Phanstiel O; Gilmour SK
Biomedicines; 2023 Oct; 11(10):. PubMed ID: 37893077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
